# q03 rev 0 - blind solver B (raw, verbatim)

- Date: 2026-10-06. Fresh blind-solver agent (claude-opus-5-5, omitClaudeMd, scope hook), given only
  the workspace root, the solver-2 packet path and the question. Copied verbatim from the task
  notification.
- tested_sha256: 40a1754e52b63814906853c94e992a3af44260ee1af1768c123c67b161b1771c

## Return

**Answer: 37.04%.** Russia and Belarus made about $80M of operating profit on about $216M of net sales in 2024 (80 / 216 = 37.04%). No document states these figures directly. I worked them out as the change in Colgate's 2024 Asia Pacific figures when the company recast its segments.

answer: 37.04% (2024 operating profit of about $80M on net sales of about $216M)

confidence: high

path:
1. **What moved where (D11, Q1 2026 release, line 85, footnote (1)):** "Russia and Belarus, which were previously reported within the Africa/Eurasia reportable operating segment, are now reported within the Asia Pacific reportable operating segment." The same footnote says the other changes merged Europe, Africa/Eurasia (excluding Russia and Belarus) and skin health into a new Europe, Middle East &amp; Africa segment. Asia Pacific's only change is therefore the addition of Russia and Belarus.
2. **Asia Pacific 2024, new structure (D10, recast exhibit dated 2026-03-17, lines 44–59, "Year Ended December 31, 2024"):** "| Asia Pacific | 3,074 | 1,144 | 1,061 | (23) | 892 |". The columns are net sales, cost of sales, SG&amp;A, other (income) expense and operating profit. The row adds up: 3,074 − 1,144 − 1,061 + 23 = 892.
3. **D10 is the recast D11 describes:** D11's recast Q1 2025 figures (Asia Pacific 738 / 204; Europe, Middle East &amp; Africa 1,007 / 222; lines 369–388) match D10's Q1 2025 table exactly (lines 160–166).
4. **Asia Pacific 2024, old structure without Russia and Belarus (D05, Q4 2024 release, Table 5, lines 460 and 477):** "| Asia Pacific | 724 | 698 | 2,858 | 2,782 |" (net sales) and "| Asia Pacific | 211 | 203 | 812 | 767 |" (operating profit). D09, the Q4 2025 release, repeats 2,858 and 812 for 2024 (lines 463 and 480). The July 2024 recast only moved skin health from Europe to North America (D05, line 113), so it did not affect Asia Pacific.
5. **Calculation:**
   - Net sales: 3,074 − 2,858 = 216
   - Operating profit: 892 − 812 = 80
   - Margin: 80 / 216 = 0.370370… = **37.04%**
6. **Cross-check through the other segments:**
   - Skin health = old North America minus new North America: net sales 4,113 − 3,716 = 397; operating profit 839 − 856 = −17.
   - Russia and Belarus = old Europe + old Africa/Eurasia + skin health − new Europe, Middle East &amp; Africa: net sales 2,770 + 1,095 + 397 − 4,046 = 216; operating profit 658 + 253 − 17 − 814 = 80. This matches.
   - Totals agree in both structures: net sales 15,618 and operating profit 4,088 (D05 lines 462/479; D10 line 61).
   - This is not a fully independent check. Because the totals match and Latin America is unchanged (4,782 / 1,526), it follows from the same numbers. It does confirm the inputs are consistent.

minimal_documents: D10 + D11 + D05. D09 can replace D05 because it gives the same 2024 figures. D11 can't be dropped: it is the only document that mentions Russia or Belarus. D12's recast footnote doesn't say what changed.

readings:
- **Rounding:** all inputs are rounded to whole millions. If the true values were up to $1M off, the margin could range from about 36.4% (79/217) to 37.7% (81/215). Using the printed figures, it is 37.04%.
- **Other years, if the year were misread:** 2023 is (878 − 767) / (3,041 − 2,782) = 111 / 259 = 42.86%. 2025 is (820 − 760) / (3,038 − 2,814) = 60 / 224 = 26.79%. Neither is the requested year.
- The segment-bridge method above gives the same 37.04%.

gaps:
- No document gives Russia and Belarus figures directly; the answer depends on the difference method. The original-structure releases (D05/D09) only show net sales and operating profit, so the margin can't be broken down into individual expense lines.
- **What I read:**
  - Searched all 12 text files for: Russia, Belarus, recast, skin health, Eurasia and Ukraine.
  - Read in full: D10 and the manifest.
  - Read in part: the D05 and D09 segment tables, and D11 lines 70–99 and 360–404.
  - Not read beyond search hits: D01–D04, D06–D08 and D12, and the copies under docs/. The manifest says the text/ files were extracted from those plain-text sources and there are no PDFs, so no page images needed checking.

contaminated: no
